CD4 and myeloid sarcoma: Second, the elevated expression of multiple TGF-β-targeting miRNAs in naive CD4+ T cells of patients with MS impaired TGF-β signaling, and dampened Tregs development, thereby enhancing the susceptibility to developing MS (83).